Lee's Summit, MO, United States of America

Dennis Giesing

This inventor holds 23 USPTO granted patents and 11 published patent applications, plus 7 CIPO patents and 7 EPO patents, primarily in Drug Delivery Systems. Top assignees: Taris Biomedical LLC, Allergan, Inc., Aventis Pharmaceuticals Inc.. Active years: 2002-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dennis Giesing. Retrieved from https://idiyas.com/inventor/dennis-giesing

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 11)

% Patents Active = 73.9

CIPO Patents = 7 (Patent Applications = 8)

EPO Patents = 7 (Patent Applications = 17)

Average Co-Inventor Count = 1.6

ph-index = 5

Forward Citations = 101(Granted Patents)

Company Filing History:

Aventis Pharmaceuticals Inc.

patents

4. 1 out of 435

Janssen Biotech, Inc.

patents

Years Active: 2002-2026

Loading Chart...

Areas of Expertise:

Bladder Cancer

Gemcitabine

Trospium

Drug Delivery

Tumor Metastasis

Bladder Dysfunction

Prostate Treatment

Bioresorbable Systems

Bioavailability

Sustained Treatment

Pelvic Pain

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12636300 - Methods of treatment and maintenance therapy for bladder cancer using gemcitabine (2026-05-26),

2. 12582599 - Methods for treatment of bladder cancer with gemcitabine (2026-03-24),

3. 12133913 - Methods of treating overactive bladder using trospium (2024-11-05),

4. 12090292 - Drug delivery devices and methods for drug delivery (2024-09-17),

5. 12059428 - Methods of treating tumor metastasis (2024-08-13),

6. 12029749 - Methods of treatment and maintenance therapy for bladder cancer using gemcitabine (2024-07-09),

7. 11850244 - Drug delivery systems and methods for treatment of bladder dysfunction or disorder using trospium (2023-12-26),

8. 11464734 - Methods of treating overactive bladder using trospium (2022-10-11),

9. 11446322 - Methods of treating tumor metastasis (2022-09-20),

10. 11020575 - In vivo drug delivery devices and methods for drug delivery (2021-06-01),

11. 11007355 - Drug delivery devices and methods for treatment of bladder cancer with oxaliplatin (2021-05-18),

12. 10857173 - Methods of treating tumor metastasis (2020-12-08),

13. 10792297 - Methods of treatment and maintenance therapy for bladder cancer using gemcitabine (2020-10-06),

14. 10617657 - Devices and methods for sustained treatment of bladder pain and irritative voiding (2020-04-14),

15. 10543346 - Drug delivery systems and methods for treatment of bladder cancer (2020-01-28),

Title: The Innovative Journey of Dennis Giesing

Introduction: Dennis Giesing, a talented inventor hailing from Lee's Summit, MO (US), has made significant contributions to the world of innovation with his creative mind and dedication to problem-solving.

Latest Patents: Dennis Giesing holds several patents in various fields, including technology, healthcare, and consumer products. His latest patents focus on improving efficiency in renewable energy systems and enhancing user experience in wearable technology.

Career Highlights: Throughout his career, Dennis Giesing has worked with leading tech companies to bring his inventions to life. His innovative solutions have garnered recognition for their practicality and impact on society.

Collaborations: Dennis Giesing has collaborated with top researchers and engineers to push the boundaries of technology. His partnerships have led to groundbreaking inventions that have shaped industries and improved the quality of life for many.

Conclusion: Dennis Giesing's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His contributions to the field of technology and beyond have left a lasting legacy that will be remembered for years to come.

Profile summary based on public USPTO records.